| Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017 CE Troeger, IA Khalil, BF Blacker, MH Biehl, SB Albertson, SRM Zimsen, ... The Lancet Infectious Diseases 20 (1), 37-59, 2020 | 155 | 2020 |
| Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient … MW Moses, P Pedroza, R Baral, S Bloom, J Brown, A Chapin, K Compton, ... The Lancet Public Health 4 (1), e49-e73, 2019 | 95 | 2019 |
| Indirect rotavirus vaccine effectiveness for the prevention of rotavirus hospitalization: a systematic review and meta-analysis KL Rosettie, T Vos, AH Mokdad, AD Flaxman, I Khalil, C Troeger, ... The American journal of tropical medicine and hygiene 98 (4), 1197, 2018 | 34 | 2018 |
| Comparative risk assessment of school food environment policies and childhood diets, childhood obesity, and future cardiometabolic mortality in the United States KL Rosettie, R Micha, F Cudhea, JL Penalvo, M O’Flaherty, ... PLoS One 13 (7), e0200378, 2018 | 29 | 2018 |
| Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis KL Rosettie, JN Joffe, GW Sparks, A Aravkin, S Chen, K Compton, ... PLoS One 16 (12), e0260808, 2021 | 18 | 2021 |
| The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis KA Freedberg, C Possas, S Deeks, AL Ross, KL Rosettie, M Di Mascio, ... Journal of virus eradication 1 (4), 245-249, 2015 | 18 | 2015 |
| Priority interventions to improve maternal and child diets in S ub‐S aharan A frica and S outh A sia WA Masters, K Rosettie, S Kranz, SH Pedersen, P Webb, G Danaei, ... Maternal & child nutrition 14 (2), e12526, 2018 | 17 | 2018 |
| Designing programs to improve diets for maternal and child health: estimating costs and potential dietary impacts of nutrition-sensitive programs in Ethiopia, Nigeria, and India WA Masters, KL Rosettie, S Kranz, G Danaei, P Webb, D Mozaffarian Health policy and planning 33 (4), 564-573, 2018 | 15 | 2018 |
| Modelling the potential cost-effectiveness of food-based programs to reduce malnutrition P Webb, G Danaei, WA Masters, KL Rosettie, AA Leech, J Cohen, ... Global food security 29, 100550, 2021 | 14 | 2021 |
| The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations EP Hyle, IV Jani, KL Rosettie, R Wood, B Osher, S Resch, PP Pei, ... Aids 31 (15), 2135-2145, 2017 | 13 | 2017 |
| Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis MM Janko, J Joffe, D Michael, L Earl, KL Rosettie, GW Sparks, ... Vaccine 40 (28), 3903-3917, 2022 | 5 | 2022 |
| Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study A Briggs, N Paracha, K Rosettie, A Upton, C Bokemeyer, U Lassen, ... Oncology 100 (2), 124-130, 2022 | 1 | 2022 |
| COST-EFFECTIVENESS OF ATEZOLIZUMAB MONOTHERAPY VERSUS PEMBROLIZUMAB MONOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER CW Lin, K Rosettie, SP Bilir, H Celik, S Abogunrin, S Ogale VALUE IN HEALTH 24, S37-S37, 2021 | 1 | 2021 |
| Cost-effectiveness of atezolizumab monotherapy versus pembrolizumab monotherapy for first-line (1L) treatment of metastatic non-small cell lung cancer (mNSCLC). CW Lin, K Rosettie, P Bilir, H Celik, S Abogunrin, S Ogale Journal of Clinical Oncology 39 (15_suppl), e18847-e18847, 2021 | 1 | 2021 |
| Como assumir compromissos SMART de ação em prol da nutrição: Relatório sobre a nutrição mundial nota de orientação J Fanzo, C Hawkes, K Rosettie Intl Food Policy Res Inst, 2016 | 1 | 2016 |
| Estimates of Productivity Loss Due to Neurological Diseases in the United States (P7-4.007) J Fox, E Mearns, T Majda, KL Rosettie, N Win, S Kowal Neurology 102 (17_supplement_1), 3437, 2024 | | 2024 |
| Disease Burden of Neurological Disorders in Underserved Populations Across the US in 2022 (S43. 007) A Patel, E Mearns, S Kowal, K Rosettie, N Win Neurology 102 (17_supplement_1), 3658, 2024 | | 2024 |
| Glofitamab Results in Cost Savings Versus Epcoritamab in Diffuse Large B-Cell Lymphoma (DLBCL): A Total Cost of Care Analysis Z Mahmoudjafari, D Di Maio, J Li, KL Rosettie, A Masaquel Blood 142, 3703, 2023 | | 2023 |
| ABCL-504 Population Health and Economic Benefits of Pola-R-CHP versus R-CHOP in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in the United States A Masaquel, J Li, R Ho, D Fox, KL Rosettie, F El Moustaid, TT Qu, Y Meng Clinical Lymphoma Myeloma and Leukemia 23, S438-S439, 2023 | | 2023 |
| POSTER: ABCL-504 Population Health and Economic Benefits of Pola-R-CHP versus R-CHOP in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in the United … A Masaquel, J Li, R Ho, D Fox, KL Rosettie, F El Moustaid, TT Qu, Y Meng Clinical Lymphoma Myeloma and Leukemia 23, S203, 2023 | | 2023 |
